Six questions with Incyclix Bio CEO Patrick Roberts By: Triangle Business Journal via Business Journals March 31, 2022 at 08:13 AM EDT The RTP-based oncology company launched two years ago and is now looking to grow its headcount as it moves toward clinical trials. Read More >> Related Stocks: Harbor Disruptive Innovation ETF
